Antibody produced in response to a vaccine SARS-CoV-2 coronavirus Antibody produced in response to a vaccine SARS-CoV-2 coronavirus Antibody produced in response to a vaccine SARS-CoV-2 coronavirusWork began in January with the deciphering of the SARS-CoV-2 genome. The first vaccine safety trials in humans started in March, but the road ahead remains uncertain. The Vaccine Testing ProcessThe development cycle of a vaccine, from lab to clinic. PHASE I PHASE IIIn May, the Maryland-based Novavax started a Phase I/II trial on a vaccine made up of microscopic particles carrying fragments of coronavirus proteins. PHASE I PHASE IIThe state-owned Chinese company Sinopharm has started Phase I/II trials on two inactivated vaccine viruses.

Source: New York Times June 10, 2020 09:01 UTC